Objective:Thrombin generated during the active clotting of blood appears to be a potent uterotonic agonist; however, the mechanism underlying this effect on uterine smooth muscle is not well understood. We performed studies to confirm the uterotonic effects of thrombin and to determine whether prostaglandin production plays a role during the uterotonic effects of thrombin or clotting blood.
Methods:Uterine contraction studies were performed using adult nonpregnant and near-term pregnant rats. The in vitro isometric contraction studies used uterine strips pretreatd with indomethacia or vehicle (ethanol), which were then stimulated with thrombin. Forthe in vivo contraction studies, rats were pretreated with intraperitoneal injections of indomethacia or vehicle (ethanol) then stimulated by intraluminal injection of fresh rat blood or thrombin into the uterus. The contraction data were acquired using isometric force traducers, were computer digized, normalized for spontaneous activity, and statistically analyzed. Prostaglandin (PG) F2α was measured using an enzyme-linked immunoassay.
Results:The in vitro contraction studies demonstrated that both thrombin and actively clotting blood produce a significant increase in the frequency and intensity of uterine contractions. Thrombin stimulation was associated with a 54% increase in PGF2α concentration in vitro; indomethacin (1 μM) pretreatment completely inhibited that increase in PGF2α production. Despite the suppression of PGF2α production, pretreatment with indomethacin had no inhibitory effect on thrombin-stimulated contractile activity. In vivo contraction studies further confirmed that indomethacin (2 mg/kg) pretreatment had no effect on blood- or thrombin-stimulated contractile activity.
Conclusions:We confirmed that thrombin andthrombin produced by actively clotting blood had a robust uterotonic effect in the rat and that prostaglandin production did not play a significant role in thrombin-stimulated contractions.
1. Grand RJA, Turnell AS, Grabham PW. Cellular consequences of thrombin-receptor activation. Biochem J1996;313:353-368.
2.
2. Dery O, Corvera CU, Steinhoff M, Bunnett NW. Proteinase-activated receptors: Novel mechanisms of signaling by serine proteases. Am J Physiol1998;274:C1429-C1452.
3.
3. Vu TH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell1991;64:1057-1068.
4.
4. Ishihara H, Connolly AJ, Zeng D, et al. Protease activated receptor 3 is a second thrombin receptor in humans. Nature1997;386:502-506.
5.
5. Kahn ML, Hammes SR, Botka C, Coughlin SR. Gene and locus structure and chromosomal localization of the protease-activated receptor gene family. J Biol Chem1998;273:23290-23296.
6.
6. Elovitz M, Ascher-Landsberg J, Saunders T, Phillippe M. The mechanisms underlying the stimulatory effects of thrombin on myometrial smooth muscle. Am J Obstet Gynecol2000;183:674-681.
7.
7. Elovitz M, Saunders T, Ascher-Landsberg J, Phillippe M. The effects of thrombin on myometrial contractions, in vitro and in vivo. Am J Obstet Gynecol2000;183:799-804.
8.
8. Phillippe M, Saunders T, Basa A. Intracellular mechanisms underlying prostaglandin F2α-stimulated phasic myometrial contractions. Am J Physiol1997;273:E664-E673.
9.
9. Phillippe M, Basa A. (+)-cis-Dioxolane stimulation of cytosolic calcium oscillations and phasic contractions of myometrial smooth muscle. Biochem Biophys Res Commun1997;231:722-725.
10.
10. Phillippe M, Chien E. Intracellular signaling and phasic myometrial contractions. J Soc Gynecol Investig1998;5:169-177.
11.
11. Ku C, Qian A, Wen Y, Answer K, Sanborn B. Oxytocin stimulates myometrial gyanosine triphosphate and phospholipase C activities via coupling to Gq/11. Endocrinology1995;136:1509-1515.
12.
12. Young R, Hession R. Intra- and intercellular calcium waves in cultured human myometrium. J Muscle Res Cell Motil1996;17:349-355.
13.
13. Luckas MJM, Taggart MJ, Wray S. Intracellular calcium stores and agonist-induced contractions in isolated human myometrium. Am J Obstet Gynecol1999;181:468-476.
14.
14. Goureau O, Tanfin Z, Marc S, Harbor S. Diverse prostaglandin receptors activatedistinct signal transduction pathways in rat myometrium. Am J Physiol1992;263:C257-C265.
15.
15. Whalley ET. Reduction in vivo of uterine responses to bradykinin by indomethacin in the rat. J Pharm Pharmacol1979;31:486-487.
16.
16. Whittle BJR, Higgs GA, Eakins KE, Moncada S, Vane JR. Selective inhibition of prostaglandin production in inflammatory excudates and gastric mucosa. Nature1980;284:271-273.
17.
17. Fareed J, Kindel G, Kumar A. Modulation of smooth muscle responses by serine proteases and related enzymes. Semin Thromb Hemost1986;12:265-276.
18.
18. Nakayama K, Hashimoto K. Blood components and cerebral vasospasm. Bibliotheca Cardiologica1984;38:148-160.
19.
19. Huack RW, Schulz C, Schomig A, Hoffman RK, Panettieri RA. α-Thrombin stimulates contraction of human bronchial rings by activation of protease-activated receptors. Am J Physiol1999;277:L22-L29.
20.
20. Hollenberg MD, Yang SG, Laniyonu AA, Moore GJ, Saifeddine M. Action of thrombin receptor polypeptide in gastric smooth muscle: Identification of a core pentapeptide retaining full thrombin-mimetic intrinsic activity. Mol Pharmacol1992;42:186-191.
21.
21. Uszynski M, Rutkowska L. Oxytocic action of thrombin upon rat's uterus in vitro. Ginekologia Polska1975;46:783-786.
22.
22. Sawdy R, Knock GA, Bennett PR, Poston L, Aaronson PI. Effect of nimesulide and indomethacin on contractility and the Ca2+ channel current in myometrial smooth muscle from pregnant women. Br J Pharmacol1998;125:1212-1217.
